Skin beautification with oral non-hydrolized versions of carnosine and carcinine: Effective therapeutic management and cosmetic skincare solutions against oxidative glycation and free-radical production as a causal mechanism of diabetic complications and skin aging

References

• Cohen MP. Diabetes and protein glycation. New York: Springer-Verlag; 1986; 140 pp.
   Google Scholar
• Sell DR, Monnier VM. Isolation, purification and partial characterization of novel fluorophores from aging human insoluble collagen-rich tissue. Connect Tissue Res. 1989;19(1):77–92.
   PubMedGoogle Scholar
• Dunn JA, Patrick JS, Thorpe SR, Baynes JW. Oxidation of glycated proteins: Age-dependent accumulation of Nϵ-(carboxymethyl)lysine in lens proteins. Biochemistry. 1989;28:9464–9468.
   PubMed Web of Science ®Google Scholar
• Dunn JA, McCance DR, Thorpe SR, Lyons TJ, Baynes JW. Age-dependent accumulation of Nϵ-(carboxymethyl)lysine and Nϵ-(carboxymethyl)hydroxylysine in human skin collagen. Biochemistry. 1991;30:1205–1210.
   PubMed Web of Science ®Google Scholar
• Dyer DG, Blackledge JA, Katz BM, Hull CJ, Adkisson HD, Thorpe SR, The Maillard reaction in vivo. Z Ernahrungswiss. 1991;30:29–45.
   PubMedGoogle Scholar
• Sell DR, Monnier VM. Structure elucidation of a senescence cross-link from human extracellular matrix: Implication of pentoses in the aging process. J Biol Chem. 1989;264:21597–21622.
   PubMed Web of Science ®Google Scholar
• Grandhee SK, Monnier VM. Mechanism of formation of the Maillard protein cross-link, pentosidine: Glucose, fructose and ascorbate as pentosidine precursors. J Biol Chem. 1991;266:11 649–11 653.
   Google Scholar
• Dyer DG, Blackledge JA, Thorpe SR, Baynes JW. Formation of pentosidine during nonenzymatic browning of protein by glucose: Identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo. J Biol Chem. 1991;266:11 654–11 660.
   Google Scholar
• Baynes JW. Perspectives in diabetes: Role of oxidative stress in development of complications in diabetes. Diabetes. 1991;40:405–412.
   PubMed Web of Science ®Google Scholar
• Dunn JA, Ahmed MU, Murtiashaw MH, Richardson JM, Walla MD, Thorpe SR, Reaction of ascorbate with lysine and protein under autoxidizing conditions: Formation of Nϵ-(carboxymethyl)lysine by reaction between lysine and products of autoxidation of ascorbate. Biochemistry. 1990;29:10 964–10 970.
   Google Scholar
• Monnier VM, Kohn RR, Cerami A. Accelerated age-related browning of human collagen in diabetes mellitus. Proc Natl Acad Sci U S A. 1984;81:583–587.
   PubMed Web of Science ®Google Scholar
• Sell DR, Monnier VM. End-stage renal disease and diabetes catalyze the formation of a pentose-derived crosslink from aging human collagen. J Clin Invest. 1990;75:380–384.
   Google Scholar
• Esterbauer H, Schuer RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde and related aldehyde. Free Radic Biol Med. 1991;11:81–128.
   PubMed Web of Science ®Google Scholar
• Wells-Knecht KJ, Zyzak DV, Litchfield JE, Thorpe SR, Baynes JW. Mechanism of autoxidative glycosylation: Identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose. Biochemistry. 1995;34:3702–3709.
   PubMed Web of Science ®Google Scholar
• Glomb MA, Monnier VM. Mechanism of protein modification by glyoxal and glycolaldehyde, reactive intermediates of the Maillard reaction. J Biol Chem. 1995;270:10 017–10 026.
   Google Scholar
• Thornalley PJ, Battah S, Ahmed N, Karachalias N, Agalou S, Babaei-Jadidi R, Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry. Biochem J. 2003;375:581–592.
   PubMed Web of Science ®Google Scholar
• Ames JM. Mass spectrometry to detect the site specificity of advanced glycation/lipoxidation end-product formation on protein: Some challenges and solutions. Biochem Soc Trans. 2008;36(Pt 5):1051–1054.
   PubMedGoogle Scholar
• Pamplona R. Membrane phospholipids, lipoxidative damage and molecular integrity: A causal role in aging and longevity. Biochim Biophys Acta. 2008;1777(10):1249–1262.
   PubMedGoogle Scholar
• Orlando G, Bengmark S. [Advanced glycation and lipoxidation end-products amplify inflammation. The role of a healthy diet.] Minerva Med. 2008;99(3):289–306.
   Google Scholar
• Gil A, Bengmark S. [Advanced glycation and lipoxidation end products—amplifiers of inflammation: The role of food.] Nutr Hosp. 2007;22(6):625–640.
   PubMedGoogle Scholar
• Stitt AW, Frizzell N, Thorpe SR. Advanced glycation and advanced lipoxidation: Possible role in initiation and progression of diabetic retinopathy. Curr Pharm Des. 2004;10(27):3349–3360.
   PubMedGoogle Scholar
• Wolff SP, Dean RT. Glucose autoxidation and protein modification. The potential role of ‘autoxidative glycosylation’ in diabetes. Biochem J. 1987;245(1):243–250.
   PubMed Web of Science ®Google Scholar
• Harman D. The aging process. Proc Natl Acad Sci U S A. 1981;78(11):7124–7128.
   PubMedGoogle Scholar
• Harman D. The free radical theory of aging: Effect of age on serum copper levels. J Gerontol. 1965;20:151–153.
   PubMedGoogle Scholar
• Noto R, Alicata R, Sfogliano L, Neri S, Bifarella M. A study of cupremia in a group of elderly diabetics. Acta Diabetol Lat. 1983;20(1):81–85.
   PubMedGoogle Scholar
• Vasan S, Foiles PG, Founds HW. Therapeutic potential of AGE inhibitors and breakers of AGE protein cross-links. Expert Opin Investig Drugs. 2001;10(11):1977–1987.
   PubMedGoogle Scholar
• Forbes JM, Soulis T, Thallas V, Panagiotopoulos S, Long DM, Vasan S, Renoprotective effects of a novel inhibitor of advanced glycation. Diabetologia. 2001;44(1):108–114.
   PubMedGoogle Scholar
• Wilkinson-Berka JL, Kelly DJ, Koerner SM, Jaworski K, Davis B, Thallas V, ALT-946 and aminoguanidine, inhibitors of advanced glycation, improve severe nephropathy in the diabetic transgenic (mREN-2)27 rat. Diabetes. 2002;51(11):3283–3289.
   PubMedGoogle Scholar
• Booth AA, Khalifah RG, Todd P, Hudson BG. In vitro kinetic studies of formation of antigenic advanced glycation end products (AGEs). Novel inhibition of post-Amadori glycation pathways. J Biol Chem. 1997;272(9):5430–5437.
   PubMedGoogle Scholar
• Stracke H, Hammes HP, Werkmann D, Mavrakis K, Bitsch I, Netzel M, Efficacy of benfotiamine versus thiamine on function and glycation products of peripheral nerves in diabetic rats. Exp Clin Endocrinol Diabetes. 2001;109(6):330–336.
   PubMedGoogle Scholar
• Onorato JM, Jenkins AJ, Thorpe SR, Baynes JW. Pyridoxamine, an inhibitor of advanced glycation reactions, also inhibits advanced lipoxidation reactions. Mechanism of action of pyridoxamine. J Biol Chem. 2000;275(28):21 177–21 184.
   Google Scholar
• Nakamura S, Makita Z, Ishikawa S, Yasumura K, Fujii W, Yanagisawa K, Progression of nephropathy in spontaneous diabetic rats is prevented by OPB-9195, a novel inhibitor of advanced glycation. Diabetes. 1997;46(5):895–899.
   PubMed Web of Science ®Google Scholar
• Schwedler SB, Verbeke P, Bakala H, Weiss MF, Vilar J, Depreux P, N-phenacylthiazolium bromide decreases renal and increases urinary advanced glycation end products excretion without ameliorating diabetic nephropathy in C57BL/6 mice. Diabetes Obes Metab. 2001;3(4):230–239.
   PubMedGoogle Scholar
• Forbes JM, Thallas V, Thomas MC, Founds HW, Burns WC, Jerums G, The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes. FASEB J. 2003;17(12):1762–1764.
   PubMedGoogle Scholar
• Vaitkevicius PV, Lane M, Spurgeon H, Ingram DK, Roth GS, Egan JJ, A cross-link breaker has sustained effects on arterial and ventricular properties in older rhesus monkeys. Proc Natl Acad Sci U S A. 2001;98(3):1171–1175.
   PubMedGoogle Scholar
• Sebekova K, Schinzel R, Munch G, Krivosikova Z, Dzurik R, Heidland A. Advanced glycation endproduct levels in subtotally nephrectomized rats: Beneficial effects of angiotensin II receptor 1 antagonist losartan. Miner Electrolyte Metab. 1999;25:380–383.
   PubMedGoogle Scholar
• Miyata T, van Ypersele de Strihou C, Ueda Y, Ichimori K, Inagi R, Onogi H, Angiotensin II receptor antagonists and angiotensin-converting enzyme inhibitors lower in vitro the formation of advanced glycation end products: Biochemical mechanisms. J Am Soc Nephrol. 2002;13(10):2478–2487.
   PubMed Web of Science ®Google Scholar
• Parving HH, Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, [Effect of losartan on renal and cardiovascular complications of patients with type 2 diabetes and nephropathy.] Ugeskr Laeger. 2001;163(40):5514–5519.
   PubMedGoogle Scholar
• Parving HH, Hommel E, Jensen BR, Hansen HP. Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients. Kidney Int. 2001;60(1):228–234.
   PubMedGoogle Scholar
• Severin SE. Problems concerned with the biological activity of naturally occurring imidazole compounds. Proceedings of the Plenary Session of the Seventh International Biochemical Congress, 1964, NY; pp. 45–61.
   Google Scholar
• Boldyrev AA, Severin SE. The histidine-containing dipeptides, carnosine and anserine: Distribution, properties and biological significance. Adv Enzyme Regul. 1990;30:175–194.
   PubMedGoogle Scholar
• Lenney JF. Specificity and distribution of mammalian carnosinase. Biochim Biophys Acta. 1976;429(1):214–219.
   PubMedGoogle Scholar
• Jackson MC, Kucera CM, Lenney JF. Purification and properties of human serum carnosinase. Clin Chim Acta. 1991;196(2–3):193–205.
   PubMedGoogle Scholar
• Lenney JF. Separation and characterization of two carnosine-splitting cytosolic dipeptidases from hog kidney (carnosinase and non-specific dipeptidase). Biol Chem Hoppe Seyler. 1990;371(5):433–440.
   PubMedGoogle Scholar
• Kunze N, Kleinkauf H, Bauer K. Characterization of two carnosine-degrading enzymes from rat brain. Partial purification and characterization of a carnosinase and a beta-alanyl-arginine hydrolase. Eur J Biochem. 1986;160(3):605–613.
   PubMedGoogle Scholar
• Aldini G, Facino RM, Beretta G, Carini M. Carnosine and related dipeptides as quenchers of reactive carbonyl species: From structural studies to therapeutic perspectives. Biofactors. 2005;24(1–4):77–87.
   PubMedGoogle Scholar
• Aldini G, Orioli M, Carini M, Maffei Facino R. Profiling histidine-containing dipeptides in rat tissues by liquid chromatography/electrospray ionization tandem mass spectrometry. J Mass Spectrom. 2004;39(12):1417–1428.
   PubMedGoogle Scholar
• Orioli M, Aldini G, Beretta G, Facino RM, Carini M. LC-ESI-MS/MS determination of 4-hydroxy-trans-2-nonenal Michael adducts with cysteine and histidine-containing peptides as early markers of oxidative stress in excitable tissues. J Chromatogr B Analyt Technol Biomed Life Sci. 2005;827(1):109–118.
   PubMedGoogle Scholar
• Reddy VP, Garrett MR, Perry G, Smith MA. Carnosine: A versatile antioxidant and antiglycating agent. Sci Aging Knowledge Environ. 2005;2005(18):pe12.
   PubMedGoogle Scholar
• Rashid I, van Reyk DM, Davies MJ. Carnosine and its constituents inhibit glycation of low-density lipoproteins that promotes foam cell formation in vitro. FEBS Lett. 2007;581(5):1067–1070.
   PubMedGoogle Scholar
• Babizhayev MA, Deyev AI, Yermakova VN, Semiletov YA, Davydova NG, Kurysheva NI, N-Acetylcarnosine, a natural histidine-containing dipeptide, as a potent ophthalmic drug in treatment of human cataracts. Peptides. 2001;22:979–994.
   PubMed Web of Science ®Google Scholar
• Babizhayev MA, Deyev AI, Yermakova VN, Semiletov YA, Davydova NG, Doroshenko VS, Efficacy of N-acetylcarnosine in the treatment of cataracts. Drugs R D. 2002;3(2):87–103.
   PubMedGoogle Scholar
• Babizhayev MA, Deyev AI, Yermakova VN, Remenschikov VV, Bours J. Revival of the lens transparency with N-acetylcarnosine. Curr Drug Ther. 2006;1:91–116.
   Google Scholar
• Babizhayev MA, Deyev AI, Yermakova VN, Brikman IV, Bours J. Lipid peroxidation and cataracts: N-acetylcarnosine as a therapeutic tool to manage age-related cataracts in human and in canine eyes. Drugs R D. 2004;5(3):125–139.
   PubMedGoogle Scholar
• Babizhayev MA. Method for topical treatment of eye disease and composition and device for said treatment. PCT Patent Application. International Publication Number WO 2004/028536 A1. International Publication Date: 8 April 2004.
   Google Scholar
• Babizhayev MA. Ophthalmic pharmacology of N-acetylcarnosine lubricant eye drops. J Pharmacol Toxicol. 2006;1(3):201–233.
   Google Scholar
• Babizhayev MA. Rejuvenation of visual functions in older adult drivers and drivers with cataract during a short-term administration of N-acetylcarnosine lubricant eye drops. Rejuvenation Res. 2004;7:186–198.
   PubMed Web of Science ®Google Scholar
• Babizhayev MA, Yermakova VN, Deyev AI, Seguin M-C. Imidazole-containing peptidomimetic NACA as a potent drug for the medicinal treatment of age-related cataract in humans. J Anti Aging Med. 2000;3:43–62.
   Google Scholar
• Arnould JM, Frentz R. Presence, isolation and chemical structure of a substance characteristic of cardiac tissue in Carcinus maenas (L.): Beta-alanylhistamine. Comp Biochem Physiol C. 1975;50(1):59–66.
   PubMedGoogle Scholar
• Brotman DN, Flancbaum L, Fitzpatrick JC, Fisher H. Presence of carcinine (β-alanylhistamine) in mammalian tissues. FASEB J. 1989;3:1028.
   Google Scholar
• Brotman DN, Flancbaum L, Kang YH, Merrill GF, Fisher H. Positive inotropic effects of carcinine in the isolated, perfused guinea pig heart. Crit Care Med. 1990;18:317–321.
   PubMed Web of Science ®Google Scholar
• Flancbaum L, Brotman DN, Fitzpatrick JC, Van Es T, Kasziba E, Fisher H. Existence of carcinine, a histamine-related compound, in mammalian tissues. Life Sci. 1990;47:1587–1593.
   PubMed Web of Science ®Google Scholar
• Ali SM, Tedford CE, Gregory R, Handley MK, Yates SL, Hirth WW, Design, synthesis, and structure—activity relationships of acetylene-based histamine H3 receptor antagonists. J Med Chem. 1999;42:903–909.
   PubMed Web of Science ®Google Scholar
• Tedford CE, Phillips JG, Gregory R, Pawlowski GP, Fadnis L, Khan MA, Development of trans-2-[1H-imidazol-4-yl] cyclopropane derivatives as new high-affinity histamine H3 receptor ligands. J Pharmacol Exp Ther. 1999;289:1160–1168.
   PubMed Web of Science ®Google Scholar
• Yates SL, Phillips JG, Gregory R, Pawlowski GP, Fadnis L, Khan MA, Identification and pharmacological characterization of a series of new 1H-4-substituted-imidazoyl histamine H3 receptor ligands. J Pharmacol Exp Ther. 1999;289(2):1151–1159.
   PubMedGoogle Scholar
• Tozer MJ, Kalindjian SB. Histamine H3 receptor antagonists. Expert Opin Ther Pat. 2000;10:1045–1055.
   Web of Science ®Google Scholar
• Babizhayev MA. Biological activities of the natural imidazole-containing peptidomimetics n-acetylcarnosine, carcinine and L-carnosine in ophthalmic and skin care products. Life Sci. 2006;78(20):2343–2357.
   PubMedGoogle Scholar
• Babizhayev MA, Seguin MC, Gueyne J, Evstigneeva RP, Ageyeva EA, Zheltukhina GA. L-carnosine (beta-alanyl-L-histidine) and carcinine (beta-alanylhistamine) act as natural antioxidants with hydroxyl-radical-scavenging and lipid-peroxidase activities. Biochem J. 1994;304(Pt 2):509–516.
   PubMedGoogle Scholar
• Arnould JM, Frentz R. Carcinine (β-alanyl-histamine): Rapid synthesis and action on vertebrate blood pressure. Arch Int Physiol Biochim. 1977;85(2):339–350.
   PubMedGoogle Scholar
• Prausnitz MR, Mitragotri S, Langer R. Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov. 2004;3:115–124.
   PubMed Web of Science ®Google Scholar
• Wertz PW. Lipids and barrier function of the skin. Acta Derm Venereol Suppl (Stockh). 2000;208:7–11.
   PubMedGoogle Scholar
• Requena JR, Fu MX, Ahmed MU, Jenkins AJ, Lyons TJ, Baynes JW, Quantification of malondialdehyde and 4-hydroxynonenal adducts to lysine residues in native and oxidized human low-density lipoprotein. Biochem J. 1997;322(Pt 1):317–325.
   PubMedGoogle Scholar
• Thornalley PJ. Monosaccharide autoxidation in health and disease. Environ Health Perspect. 1985;64:297–307.
   PubMed Web of Science ®Google Scholar
• Stewart JJP. MOPAC. F.J. Seiler Research Laboratory, Air Force Academy, Boulder, 1989. pp. 80840.
   Google Scholar
• Stewart JJ. MOPAC ver 6., QCPE Bull., 1989;9:10. Revised as ver. 6.01 by T. Hirano, University of Tokyo, for HITAC and UNIX machines (JCPE Newsletter. 1989;1:10).
   Google Scholar
• Babizhayev MA. Antioxidant activity of L-carnosine, a natural histidine-containing dipeptide in crystalline lens. Biochimica et Biophysica Acta. 1989;1004:363–371.
   PubMed Web of Science ®Google Scholar
• Babizhayev MA, Bozzo Costa E. Lipid peroxide and reactive oxygen species generating systems of the crystalline lens. Biochimica et Biophysica Acta. 1994;1225:326–337.
   PubMed Web of Science ®Google Scholar
• Yoshikawa T, Naito Y, Tanigawa T, Yoneta T, Kondo M. The antioxidant properties of a novel zinc–carnosine chelate compound, N-(3-aminopropionyl)-l-histidinato zinc. Biochim Biophys Acta. 1991;1115(1):15–22.
   PubMedGoogle Scholar
• Iacazio G, Langrand G, Baratti J, Buono G, Triantaphylides CJ. Preparative, enzymatic synthesis of linoleic acid (13S)-hydroperoxide using soybean lipoxygenase-1. Organic Chemistry. 1993;55:1690.
   Google Scholar
• Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680–685.
   PubMed Web of Science ®Google Scholar
• Sammons DW, Adams LD, Nishizawa EE. Ultra sensitive silver based color staining of polypeptides in polyacrylamide gels. Electrophoresis. 1981;2:135.
   Web of Science ®Google Scholar
• Guiotto A, Ruzza P, Babizhayev MA, Calderan A. Malondialdehyde scavenging and aldose-derived Schiff bases’ transglycation properties of synthetic histidyl-hydrazide carnosine analogs. Bioorg Med Chem. 2007;15(18):6158–6163.
   PubMed Web of Science ®Google Scholar
• Szwergold BS. Carnosine and anserine act as effective transglycating agents in decomposition of aldose-derived Schiff bases. Biochem Biophys Res Commun. 2005;336(1):36–41.
   PubMed Web of Science ®Google Scholar
• Babizhayev MA, Meguro K. Combined use of carnosinase inhibitor with L-carnosines and composition. WO 2004/064866 PCT/JP2004/000351. Filed 20 January 2003 (20.01.2003).
   Google Scholar
• Bando K, Shimotsuji T, Toyoshima H, Hayashi C, Miyai K. Fluorometric assay of human serum carnosinase activity in normal children, adults and patients with myopathy. Ann Clin Biochem. 1984;21(Pt 6):510–514.
   PubMedGoogle Scholar
• Tronnier H, Wiebusch M, Heinrich U, Stute R. Surface evaluation of living skin. Adv Exp Med Biol. 1999;455:507–516.
   PubMedGoogle Scholar
• Tronnier H, Wiebusch M, Heinrich U, Stute R. Zur Bewertung der Oberflachenstruktur der Haut (SELS). Act Dermatol. 1997;23:290-295.
   Google Scholar
• Khazaka G. Information and operating instructions for the Visioscan VC 98 and the software SELS 2000 (Surface Evaluation of the Living Skin). Cologne: CK Electronic; 2000.
   Google Scholar
• Béguin A. A novel micronutrient supplement in skin aging: A randomized placebo-controlled double-blind study. J Cosmet Dermatol. 2005;4(4):277–284.
   PubMedGoogle Scholar
• Thorpe SR, Baynes JW. Maillard reaction products in tissue proteins: New products and new perspectives. Amino Acids. 2003;25(3–4):275–281.
   PubMedGoogle Scholar
• Bourajjaj M, Stehouwer CD, van Hinsbergh VW, Schalkwijk CG. Role of methylglyoxal adducts in the development of vascular complications in diabetes mellitus. Biochem Soc Trans. 2003;31(Pt 6):1400–1402.
   PubMedGoogle Scholar
• Thornalley PJ. The glyoxalase system in health and disease. Mol Aspects Med. 1993;14(4):287–371.
   PubMedGoogle Scholar
• Lo TW, Westwood ME, McLellan AC, Selwood T, Thornalley PJ. Binding and modification of proteins by methylglyoxal under physiological conditions. A kinetic and mechanistic study with N alpha-acetylarginine, N alpha-acetylcysteine, and N alpha-acetyllysine, and bovine serum albumin. J Biol Chem. 1994;269(51):32 299–32 305.
   Google Scholar
• Suji G, Sivakami S. DNA damage during glycation of lysine by methylglyoxal: Assessment of vitamins in preventing damage. Amino Acids. 2007;33(4):615–621.
   PubMedGoogle Scholar
• Yim HS, Kang SO, Hah YC, Chock PB, Yim MB. Free radicals generated during the glycation reaction of amino acids by methylglyoxal. A model study of protein-cross-linked free radicals. J Biol Chem. 1995;270(47):28 228–28 233.
   Google Scholar
• McLaughlin JA, Pethig R, Szent-Györgyi A. Spectroscopic studies of the protein-methylglyoxal adduct. Proc Natl Acad Sci U S A. 1980;77(2):949–951.
   PubMedGoogle Scholar
• Tarpey MM, Wink DA, Grisham MB. Methods for detection of reactive metabolites of oxygen and nitrogen: In vitro and in vivo considerations. Am J Physiol Regul Integr Comp Physiol. 2004;286(3):R431–444.
   Google Scholar
• Shumaev KB, Gubkina SA, Kumskova EM, Shepelkova GS, Ruuge EK, Lankin VZ. Superoxide formation as a result of interaction of L-lysine with dicarbonyl compounds and its possible mechanism. Biochemistry (Mosc). 2009;74(4):461–466.
   PubMedGoogle Scholar
• Bisby RH, Parker AW. Reactions of the alpha-tocopheroxyl radical in micellar solutions studied by nanosecond laser flash photolysis. FEBS Lett. 1991;290(1–2):205–208.
   PubMedGoogle Scholar
• Aldini G, Carini M, Beretta G, Bradamante S, Facino RM. Carnosine is a quencher of 4-hydroxy-nonenal: Through what mechanism of reaction? Biochem Biophys Res Commun. 2002;298:699–706.
   PubMed Web of Science ®Google Scholar
• Pegova A, Abe H, Boldyrev A. Hydrolysis of carnosine and related compounds by mammalian carnosinases. Comp Biochem Physiol B Biochem Mol Biol. 2000;127:443–446.
   PubMed Web of Science ®Google Scholar
• Babizhayev MA. Ocular drug metabolism of the bioactivating antioxidant N-acetylcarnosine for vision in ophthalmic prodrug and codrug design and delivery. Drug Dev Ind Pharm. 2008;34(10):1071–1089.
   PubMedGoogle Scholar
• Kang JH. Protective effects of carnosine and N-acetylcarnosine on salsolinol-mediated Cu,Zn-superoxide dismutase inactivation. Bull Korean Chem Soc. 2007;208(10):1881–1884.
   Google Scholar
• Neglia CI, Cohen HJ, Garber AR, Thorpe SR, Baynes JW. Characterization of glycated proteins by 13C NMR spectroscopy. Identification of specific sites of protein modification by glucose. J Biol Chem. 1985;260(9):5406–5410.
   PubMedGoogle Scholar
• Mossine VV, Glinsky GV, Feather MS. The preparation and characterization of some Amadori compounds (1-amino-1-deoxy-D-fructose derivatives) derived from a series of aliphatic omega-amino acids. Carbohydr Res. 1994;262(2):257–270.
   PubMedGoogle Scholar
• Babizhayev MA, Seguin M-C. Coupling product obtained from histamine and an amino acid. US Patent Number 5,792,784. Date of Patent 11 August 1998.
   Google Scholar
• Babizhayev MA, Guiotto A, Kasus-Jacobi A. N-Acetylcarnosine and histidyl-hydrazide are potent agents for multitargeted ophthalmic therapy of senile cataracts and diabetic ocular complications. J Drug Target. 2009;17(1):36–63.
   PubMedGoogle Scholar
• Conner JR, Beisswenger PJ, Szwergold BS. Some clues as to the regulation, expression, function, and distribution of fructosamine-3-kinase and fructosamine-3-kinase-related protein. Ann N Y Acad Sci. 2005;1043:824–836.
   Google Scholar
• Teufel M, Saudek V, Ledig JP, Bernhardt A, Boularand S, Carreau A, Sequence identification and characterization of human carnosinase and a closely related non-specific dipeptidase. J Biol Chem. 2003;278(8):6521–6531.
   PubMedGoogle Scholar
• Unno H, Yamashita T, Ujita S, Okumura N, Otani H, Okumura A, Structural basis for substrate recognition and hydrolysis by mouse carnosinase CN2. J Biol Chem. 2008;283(40):27 289–27 299.
   Google Scholar
• Lee YT, Hsu CC, Lin MH, Liu KS, Yin MC. Histidine and carnosine delay diabetic deterioration in mice and protect human low density lipoprotein against oxidation and glycation. Eur J Pharmacol. 2005;513(1-2):145–150.
   PubMed Web of Science ®Google Scholar
• Babizhayev MA. Current ocular drug delivery challenges for N-acetylcarnosine: Novel patented routes and modes of delivery, design for enhancement of therapeutic activity and drug delivery relationships. Recent Pat Drug Deliv Formul. 2009;3:229–265.
   PubMedGoogle Scholar
• Wolff SP. The potential role of oxidative stress in diabetes and its complications: Novel implications for theory and therapy. In: Crabbe MJC, editor. Diabetic complications. New York: Churchill Livingstone; 1987. p. 167–220.
   Google Scholar
• Godin DV, Wohaieb SA. Reactive oxygen radical processes in diabetes. In: Singal PK, editor. Oxygen radicals in the pathophysiology of heart disease. Boston: Kluwer Academic Publishers; 1988. p. 303–322.
   Google Scholar
• Oberley LW. Free radicals and diabetes. Free Radic Biol Med. 1988;5:113–124.
   PubMed Web of Science ®Google Scholar
• Wolff SP, Jiang ZY, Hunt JV. Protein glycation and oxidative stress in diabetes mellitus and ageing. Free Radic Biol Med. 1991;10:339–352.
   PubMed Web of Science ®Google Scholar
• VanderJagt DL, Robinson B, Taylor KK, Hunsaker LA. Reduction of trioses by NADPH-dependent aldo-keto reductases: Aldose reductase, methylglyoxal, and diabetic complications. J Biol Chem. 1992;267:4364–4369.
   PubMedGoogle Scholar
• Jiang ZY, Woollard AC, Wolff SP. Hydrogen peroxide production during experimental protein glycation. FEBS Lett. 1990;268(1):69–71.
   PubMedGoogle Scholar
• Hunt JV, Dean RT, Wolff SP. Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing. Biochem J. 1988;256(1):205–212.
   PubMed Web of Science ®Google Scholar
• Ahmed MU, Thorpe SR, Baynes JW. Identification of N epsilon-carboxymethyllysine as a degradation product of fructoselysine in glycated protein. J Biol Chem. 1986;261(11):4889–4894.
   PubMedGoogle Scholar
• Hipkiss AR. Would carnosine or a carnivorous diet help suppress aging and associated pathologies? Ann N Y Acad Sci. 2006;1067:369–374.
   PubMed Web of Science ®Google Scholar
• Hipkiss AR. Carnosine, diabetes and Alzheimer's disease. Expert Rev Neurother. 2009;9(5):583–585.
   PubMedGoogle Scholar
• Ukeda H, Hasegawa Y, Harada Y, Sawamura M. Effect of carnosine and related compounds on the inactivation of human Cu,Zn-superoxide dismutase by modification of fructose and glycolaldehyde. Biosci Biotechnol Biochem. 2002;66(1):36–43.
   PubMed Web of Science ®Google Scholar
• Kang JH, Kim KS, Choi SY, Kwon HY, Won MH, Kang TC. Protective effects of carnosine, homocarnosine and anserine against peroxyl radical-mediated Cu,Zn-superoxide dismutase modification. Biochim Biophys Acta. 2002;1570:89–96.
   PubMed Web of Science ®Google Scholar
• Hipkiss AR, Preston JE, Himswoth DT, Worthington VC, Abbot NJ. Protective effects of carnosine against malondialdehyde-induced toxicity towards cultured rat brain endothelial cells. Neurosci Lett. 1997;238(3):135–138.
   PubMed Web of Science ®Google Scholar
• Hipkiss AR, Worthington VC, Himsworth DT, Herwig W. Protective effects of carnosine against protein modification mediated by malondialdehyde and hypochlorite. Biochim Biophys Acta. 1998;1380(1):46–54.
   PubMed Web of Science ®Google Scholar
• Zhou S, Decker EA. Ability of carnosine and other skeletal muscle components to quench unsaturated aldehydic lipid oxidation products. J Agric Food Chem. 1999;47(1):51–55.
   PubMed Web of Science ®Google Scholar
• Aldini G, Granata P, Carini M. Detoxification of cytotoxic alpha,beta-unsaturated aldehydes by carnosine: Characterization of conjugated adducts by electrospray ionization tandem mass spectrometry and detection by liquid chromatography/mass spectrometry in rat skeletal muscle. J Mass Spectrom. 2002;37(12):1219–1228.
   PubMed Web of Science ®Google Scholar
• Hipkiss AR, Chana H. Carnosine protects proteins against methylglyoxal-mediated modifications. Biochem Biophys Res Commun. 1998;248(1):28–32.
   PubMed Web of Science ®Google Scholar
• Hipkiss AR, Michaelis J, Syrris P. Non-enzymatic glycosylation of the dipeptide L-carnosine, a potential anti-protein-crosslinking agent. FEBS Lett. 1995;371(1):81–85.
   PubMed Web of Science ®Google Scholar
• Hipkiss AR, Michaelis J, Syrris P, Kumar S, Lam Y. Carnosine protects proteins against in vitro glycation and cross-linking. Biochem Soc Trans. 1994;22(4):399S.
   PubMed Web of Science ®Google Scholar
• Brownson C, Hipkiss AR. Carnosine reacts with a glycated protein. Free Radic Biol Med. 2000;28(10):1564–1570.
   PubMed Web of Science ®Google Scholar
• Hobart LJ, Seibel I, Yeargans GS, Seidler NW. Anti-crosslinking properties of carnosine: Significance of histidine. Life Sci. 2004;75:1379–1389.
   PubMed Web of Science ®Google Scholar
• Hipkiss AR. Glycation, ageing and carnosine: Are carnivorous diets beneficial? Mech Ageing Dev. 2005;126(10):1034–1039.
   PubMed Web of Science ®Google Scholar
• Seidler NW, Yeargans GS, Morgan TG. Carnosine disaggregates glycated alpha-crystallin: An in vitro study. Arch Biochem Biophys. 2004;427:110–115.
   PubMed Web of Science ®Google Scholar
• Yamagishi S-I, Nakamura K, Imaizumi T. Advanced glycation end products (AGEs) and diabetic vascular complications. Curr Diabetes Rev. 2005;1:93–106.
   PubMedGoogle Scholar
• Hipkiss AR, Brownson C, Bertani MF, Ruiz E, Ferro A. Reaction of carnosine with aged proteins: Another protective process? Ann N Y Acad Sci. 2002;959:285–294.
   PubMed Web of Science ®Google Scholar
• Baynes JW, Thorpe SR. Glycoxidation and lipoxidation in atherogenesis. Free Radic Biol Med. 2000;28:1708–1716.
   PubMed Web of Science ®Google Scholar
• Babizhayev MA, Yegorov YE. Therapeutic uses of drug-carrier systems for imidazole-containing dipeptide compounds that act as pharmacological chaperones and have significant impact on the treatment of chronic diseases associated with increased oxidative stress and the formation of advanced glycation end products. Crit Rev Ther Drug Carrier Syst. 2010;27(2):85–154.
   PubMedGoogle Scholar
• Babizhayev MA, Nikolayev GM, Nikolayeva JG, Yegorov YE. A survey and analysis of the role of molecular chaperone proteins and imidazole-containing dipeptide-based compounds as molecular escorts into the skin during stress, injury, water structuring and other types of cutaneous pathophysiology. Int J Cosmet Sci. Epub 2010 Jun 7.
   Google Scholar
• Oturai PS, Christensen M, Rolin B, Pedersen KE, Mortensen SB, Boel E. Effects of advanced glycation end-product inhibition and cross-link breakage in diabetic rats. Metabolism. 2000;49(8):996–1000.
   PubMedGoogle Scholar